BioInvent International Current Valuation vs. Price To Sales
| BINV Stock | SEK 44.55 1.20 2.62% |
For BioInvent International profitability analysis, we use financial ratios and fundamental drivers that measure the ability of BioInvent International to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well BioInvent International AB utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between BioInvent International's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of BioInvent International AB over time as well as its relative position and ranking within its peers.
BioInvent |
BioInvent International Price To Sales vs. Current Valuation Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining BioInvent International's current stock value. Our valuation model uses many indicators to compare BioInvent International value to that of its competitors to determine the firm's financial worth. BioInvent International AB is the top company in current valuation category among its peers. It is rated fourth in price to sales category among its peers . The ratio of Current Valuation to Price To Sales for BioInvent International AB is about 159,731,589 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the BioInvent International's earnings, one of the primary drivers of an investment's value.BioInvent Current Valuation vs. Competition
BioInvent International AB is the top company in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is currently estimated at about 4.52 Billion. BioInvent International totals roughly 1.16 Billion in current valuation claiming about 26% of equities under Health Care industry.
BioInvent Price To Sales vs. Current Valuation
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
BioInvent International |
| = | 1.16 B |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
BioInvent International |
| = | 7.25 X |
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
BioInvent Price To Sales Comparison
BioInvent International is currently under evaluation in price to sales category among its peers.
BioInvent International Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in BioInvent International, profitability is also one of the essential criteria for including it into their portfolios because, without profit, BioInvent International will eventually generate negative long term returns. The profitability progress is the general direction of BioInvent International's change in net profit over the period of time. It can combine multiple indicators of BioInvent International, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
BioInvent International AB focuses on the research and development of immunomodulating antibodies for the treatment of cancer in Sweden, Europe, and internationally. The Company was founded in 1997 and is based in Lund, Sweden. BioInvent International operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. It employs 68 people.
BioInvent Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on BioInvent International. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of BioInvent International position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the BioInvent International's important profitability drivers and their relationship over time.
Use BioInvent International in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BioInvent International position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioInvent International will appreciate offsetting losses from the drop in the long position's value.BioInvent International Pair Trading
BioInvent International AB Pair Trading Analysis
The ability to find closely correlated positions to BioInvent International could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BioInvent International when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BioInvent International - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BioInvent International AB to buy it.
The correlation of BioInvent International is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BioInvent International moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BioInvent International moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BioInvent International can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your BioInvent International position
In addition to having BioInvent International in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Banking Thematic Idea Now
Banking
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Banking theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Banking Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for BioInvent Stock Analysis
When running BioInvent International's price analysis, check to measure BioInvent International's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioInvent International is operating at the current time. Most of BioInvent International's value examination focuses on studying past and present price action to predict the probability of BioInvent International's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioInvent International's price. Additionally, you may evaluate how the addition of BioInvent International to your portfolios can decrease your overall portfolio volatility.